Antitumor applications of stimulating Toll-like receptor 9 with CpG oligodeoxynucleotides

被引:174
作者
Krieg A.M. [1 ]
机构
[1] Coley Pharmaceutical Group, Wellesley, MA 02481
关键词
Chronic Lymphocytic Leukemia; Plasmacytoid Dendritic Cell; Immune Effect; Vaccine Adjuvant; Peritumoral Injection;
D O I
10.1007/s11912-004-0019-0
中图分类号
学科分类号
摘要
Tumor immunotherapy has evolved from the use of crude bacterial extracts to chemically synthesized ligands for specific immune receptors, such as Toll-like receptors (TLRs). One of the most promising targets for therapeutic immune activation is TLR9, which detects unmethylated CpG dinucleotides present in viral and prokaryotic genomes, which are generally methylated in host DNA. This review describes the immune effects of synthetic CpG oligonucleotides as TLR9 ligands and their applications in cancer immunotherapy. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:88 / 95
页数:7
相关论文
共 71 条
[1]  
Takeda K., Kaisho T., Akira S., Toll-like receptors, Annu. Rev. Immunol., 21, pp. 335-376, (2003)
[2]  
Ahmad-Nejad P., Hacker H., Rutz M., Et al., Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments, Eur. J. Immunol., 32, pp. 1958-1968, (2002)
[3]  
Bauer S., Kirschning C.J., Hacker H., Et al., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition, Proc. Natl. Acad. Sci. USA, 98, pp. 9237-9242, (2001)
[4]  
Krug A., Towarowski A., Britsch S., Et al., Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12, Eur. J. Immunol., 31, pp. 3026-3037, (2001)
[5]  
Kadowaki N., Ho S., Antonenko S., Et al., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens, J. Exp. Med., 194, pp. 863-870, (2001)
[6]  
Hornung V., Rothenfusser S., Britsch S., Et al., Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J. Immunol., 168, pp. 4531-4537, (2002)
[7]  
Hartmann G., Weeratna R.D., Ballas Z.K., Et al., Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo, J. Immunol., 164, pp. 1617-1624, (2000)
[8]  
Krieg A.M., CpG motifs in bacterial DNA and their immune effects, Annu. Rev. Immunol., 20, pp. 709-760, (2002)
[9]  
Krug A., Rothenfusser S., Hornung V., Et al., Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells, Eur. J. Immunol., 31, pp. 2154-2163, (2001)
[10]  
Krieg A.M., Yi A.K., Matson S., Et al., CpG motifs in bacterial DNA trigger direct B-cell activation, Nature, 374, pp. 546-549, (1995)